Effects of portulaca oleracea L (purslane) on psychological symptoms of chronic schizophrenic patients in Sina hospital

Journal of Mazandaran University of Medical Sciences

Volumn 23, Issue 97, 2013, Pages 2-10

  Parvin, Neda ^a   Farzane Dehkordi, Shokoh ^a   Goudarzi, Iraj ^a   Nikfarjam, Masoud ^a   Rafieian, Mahmoud ^a   Heidarian, Esfandyar ^b   Rafiee Vardanjani, Leila ^a  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Shahre Kurd University of Medical Sciences   (Iran)

Author keywords

Biperiden; Purslane; Risperidone; Schizophrenia

Indexed keywords

BIPERIDEN; C REACTIVE PROTEIN; PORTULACA OLERACEA EXTRACT; RISPERIDONE;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; POSITIVE SYNDROME; PSYCHOLOGICAL SYMPTOM; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOM;

EID: 84922686594     PISSN: 17359279     EISSN: 17359260     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mueser KT, McGurk SR. Schizophrenia. Lancet. 2004 Jun 19;363(9426):2063-2072. PMID: 15207959
2. Zhang M, Zhao ZM, He L, Wan CL. A metaanalysis of oxidative stress markers in schizophrenia. Sci China Life Sci. 2010 Jan;53(1):112-124. Epub 2010 Feb 12.PMID: 20596963.
3. Mahadik SP, Evans D, Lal H. Oxidative stress and role of antioxidant and [omega]-3 essential fatty acid supplementation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Apr;25(3):463-493. PMID: 11370992
4. Do KQ, Trabesinger AH, Kirsten-Krüger M, Lauer CJ, Dydak U, Hell D, et al. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. European Journal of Neuroscience. 2000;12(10):3721-3728. PMID: 11029642
5. Fontaine CS, Hynan LS, Koch K, Martin-Cook K, Svetlik D, WEINER MF. A doubleblind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities. J Clin Psychiatry. 2003 Jun;64(6):726-730. PMID: 12823090
6. Currier GW, Chou J, Feifel D, Bossie CA, Turkoz I, Mahmoud RA, et al. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J Clin Psychiatry. 2004 Mar;65(3):386-394. PMID: 15096079
7. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. The American Journal of Psychiatry. Am J Psychiatry. 1994 Jun;151(6):825-835. PMID: 7514366
8. Murray M. The Healing Power of Herbs, 2nd ed. Prima Publishing, Rocklin, CA 1995, p:147.
9. Ezekwe MO, Omara-Alwala TR, Membrahtu T. Nutritive characterization of purslane accessions as influenced by planting date. Plant Foods Hum Nutr. 1999;54(3):183-191. PMID: 10716400
10. Xiang L, Xing D, Wang W, Wang R, Ding Y, Du L. Alkaloids from Portulaca oleracea L. Phytochemistry. 2005 Nov;66(21):2595-2601. Epub 2005 Oct 3. PMID: 16203019
11. Yang Z, Liu C, Xiang L, Zheng Y. Phenolic alkaloids as a new class of antioxidants in Portulaca oleracea. Phytother Res. 2009 Jul;23(7):1032-1035 PMID: 19140117.
12. Asadi H, Hasandokht M, Dashti F. Comparison of fatty acids compound, oxalic acid and mineral elements of iranian purslane (portulaca oleracea l.) With forign sample. Iranian Journal Of Food Science And Technology. 2006;3(3):49-55.
13. Chan K, Islam MW, Kamil M, Radhakrishnan R, Zakaria MN, Habibullah M, et al. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. Sativa (Haw.) Celak. J Ethnopharmacol. 2000 Dec;73(3):445-451. PMID: 11090998
14. Huang TL, Lin FC. High-sensitivity Creactive protein levels in patients with major depressive disorder and bipolar mania. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):370-372. Epub 2006 Oct 24. PMID: 17064834
15. Cunha AB, Andreazza AC, Gomes FA, Frey BN, da Silveira LE, Gonçalves CA, et al. Investigation of serum high-sensitive Creactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2008 Aug;258(5):300-304. Epub 2008 Feb 23. PMID: 18297417
16. Wadee AA, Kuschke RH, Wood LA, Berk M, Ichim L, Maes M. Serological observations in patients suffering from acute manic episodes. Hum Psychopharmacol. 2002 Jun;17(4):175-179. PMID: 12404684
17. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007 May 9;31(4):952-955. Epub 2007 Mar 6. PMID: 17391822
18. Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, et al. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord. 2009 Nov;11(7):726-734. PMID: 19839997
19. Fan X, Pristach C, Liu EY, Freudenreich O, Henderson DC, Goff DC. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res. 2007 Jan 15;149(1-3):267-271. Epub 2006 Nov 16. PMID: 17112596
20. Zhang XY, Zhou DF, Zhang PY, Wu GY, Su JM, Cao LY. A double-blind, placebocontrolled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. J Clin Psychiatry. 2001 Nov;62(11):878-883. PMID: 11775047
21. Sadock BJ, Sadock VA. Kaplan and sadocks synspsis of psychiatry behavioral science clinical psychiatry.10th ed. Translated by Pour Afkari N. Tehran: Shahrab.2007;2:14.
22. Malek F, Boskabady M, Borushaki M, Tohidi M.Bronchodilatory effect of Portulaca oleracea in airways of asthmatic patients. J Ethnopharmacol. 2004 Jul;93(1):57-62. PMID: 15182905
23. Leila Rafiee Vardanjani, Najme Sahinfard, Mohamad Rahimi Madiseh, Roya Ansari Samani, Marzieh Rahimi, Neda Parvin, Fatemeh Taji Eshkaftaki. Effect of Portulaca oleracea L vice versa silver sulfadiazine on burn wound healing in Balb/c mice Shahrekord University of Medical Sciences Journal 2012;13(6): 92-100.
24. Foruzandeh N, Parvin N. Occupational therapy for inpatients with chronic schizophrenia: A pilot randomized controlled trial. Japan Journal of Nursing Science (2012) doi:10.1111/j.1742-7924.2012.00211.x
25. Sicras-Mainar A, Rejas-Gutiérrez J, Navarro-Artieda R, Blanca-Tamayo M. C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice. Eur Psychiatry. 2011 Sep 30. [Epub ahead of print]. PMID: 21964485
26. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res. 2007 Jul;93(1-3):261-265. Epub 2007 May 8. PMID: 17490859
27. Solanki R, Singh P, Singh M, Sinha M, Swami MK, Saini S. C-Reactive Protein (CRP) in patients with schizophrenia: Are they related with symptomatology? JMHHB 2009;15(1):1-6.
28. Peet M, Laugharne JD, Mellor J, Ramchand CN. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation. Prostaglandins Leukot Essent Fatty Acids. 1996 Aug;55(1-2):71-75. PMID: 8888126
29. Gatreh-Samani K, Farrokhi E, Khalili B, Rafieian M, Moradi M. [ Purslane (Portulaca oleracea) effects on serum paraoxanase-1 activity. Journal of Shahrekord University of Medical Sciences. 2011;13(1):9-14.] Persian
30. Procyshyn RM, Wasan KM, Thornton AE, Barr AM, Chen EYH, Pomarol-Clotet E, et al. Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. J Psychiatry Neurosci. 2007 Sep;32(5):331-338. PMID: 17823649
31. Sommer I, de Witte L, Begemann M, Kahn R. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? a meta-analysis. J Clin Psychiatry. 2012 Apr;73(4):414-419. Epub 2011 Dec 13. PMID: 22225599
32. Ritsner MS, Lerner V. Advancing Neuroprotective-Based Treatments for Schizophrenia. Handbook of Schizophrenia Spectrum Disorders, Volume III. 2011:51-80.